Seeking Alpha

Philip Davis'  Instablog

Philip Davis
Send Message
Philstockworld.com is the fastest growing stock and option newsletter on the Web. "High Finance for Real People - Fun and Profits" is our motto and our Basic and Premium Chat Sessions offer readers a chance to speak to Phil live during the trading day as well as authors like Optrader,... More
My company:
Phil's Stock World
My blog:
Phil's Stock World
  • PBTH & VPHM 0 comments
    May 3, 2010 3:36 PM | about stocks: SHPG, PBTH

    TA and analysis on a couple biotechs by Allan, with seal of agreement by Pharmboy, at PSW, and seal of recent insider buying (albeit 10% owners) for VPHM. These companies are presenting at conferences this week, and the stocks are highly volatile and risky, and that sword cuts both ways. So keep in mind the "sell on the news" phenomenon. - Ilene 

    PBTH & VPHM

    By Allan, guest author 

    PBTH 

    Fundamentals: 

    Pipeline Covering An Existing $25 billion Market

    Human growth hormone ($3 billion market, entering Phase II) that could potentially be injected twice per month instead of daily injections. Interferon beta for multiple sclerosis ($4.5 billion market) that may have dramatically lower side effects. Our CTP-enhanced therapeutic proteins pipeline has the potential to dominate a $25 billion market.

    CTP -- Nature's Solution To Proteins' Longevity

    CTP is a small peptide naturally found in the body as a portion of the hormone hCG, and in fact provides hCG with its superior longevity. We attach CTP to other proteins and significantly increase their longevity as well.

    Merck's FSH-CTP Approved In Europe Jan 2010
    Merck and PROLOR have the exclusive license from Washington University to utilize the CTP technology. On January 28, 2010 the European Commission (NYSE:EC) gave Merck & Co. marketing approval with unified labeling valid in all European Union Member States for FSH-CTP, now branded as ELONVA®
    Trend Models

     



    VPHM 

    Fundamentals:  

    This is a list of insider-Buys for VPHM for the past year.  Note that the last time the "Baker Brothers" (10% owner) bought shares was a year ago and at $6 a share.  One year later and at $13 a share, they are buying again.  Note also the size of the I-Buy, almost 2,000,000 shares, way more then a year ago at half the share price.  Significant?  

    Trend Models


    An interesting feature shared by both of these picks is that both company's are making presentations at Biotechnology conferences this week, VPHM on Tuesday and PBTH on Wednesday. Two stocks with their own stories to tell and possibly catapult respective share prices.  It's the game we choose to play.

    *****

    Allan’s newly launched newsletter, “Trend Following Trading Model,” goes with the trend-following trading system he’s been working on for years. Most trades last for weeks to months. Allan’s offering PSW readers a special 25% discount. Click here. For a more detailed introduction, read this introductory article

    Disclosure: allan's long vphm and pbth.ob
    Themes: biotechnology, CTP peptide Stocks: SHPG, PBTH
Back To Philip Davis' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »

Latest Comments


Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.